Clinical Trials Directory

Trials / Completed

CompletedNCT00520871

The Water-Blueberry Study

The Effect of Blueberry Juice on Cardiovascular Risk Factors, and Markers of Antioxidant Status, Oxidative Stress Status and Inflammation.

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
62 (actual)
Sponsor
University of Oslo · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

We will study the effect of supplementation of 1 L blueberry juice to participants with at least one elevated cardiovasculat risk factor.

Detailed description

Participants with at leat one elevated cardiovacsular risk factor, as defined as systolic blood pressure between 140 and 165 mmHg, diastolic blood pressure between 90 and 105 mmHg, low density lipoprotein (LDL) cholesterol ≥3.4 mmol/L, total/high density lipoprotein (HDL) cholesterol ratio \>4 or smoking a minimum of 3 cigarettes daily. Subjects were randomized to two groups, where the blueberry group were supplemented with 1 L blueberry juice per day for four weeks. The control group consumed an equal amount of water. Clinical markers, as well as biomarkers of antioxidant status, oxidative stress status and inflammation were measured in blood samples before amd after the intervention period.

Conditions

Interventions

TypeNameDescription
DRUGBlueberry juice

Timeline

Start date
2003-03-01
Completion
2004-04-01
First posted
2007-08-27
Last updated
2007-08-27

Source: ClinicalTrials.gov record NCT00520871. Inclusion in this directory is not an endorsement.

The Water-Blueberry Study (NCT00520871) · Clinical Trials Directory